The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF)

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.4K citations · Full text

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu, Martine Rémy‐Jardin, Jeffrey L. Myers et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 3.9K citations

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.8K citations · Full text

Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

Hiren Mandaliya, Mark Jones, Christopher Oldmeadow et al. · Translational Lung Cancer Research · 2019 · 374 citations · Full text

The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis

Sara Tomassetti, Christian Gurioli, Jay H. Ryu et al. · CHEST Journal · 2014 · 307 citations

Antifibrotic Therapy, Advanced Lung Disease, Medicine +9